References

1) Lindqvist U et al. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet 2002; 41: 603 13.
 
2) Larsen NE et al. Clearance kinetics of a single injection cross-linked hylan-based viscosupplement in a rabbit model. Osteoarth Cart 2007; 15(Suppl. C): C64.
 
3) Brown TJ et al. Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol 1991; 76: 125-134.
 
4) Harrison A, Jerome C, Böttger, M, and Schaible, H.G. Anti-nociceptive effects of DUROLANE in a model of joint pain. Poster presented at the Orthopedic Research Society Meeting 2009. Transactions Vol.34, Las Vegas, NV, 2009 Abstract: 1137.
 
5) Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2004;12:642–649.
 
6) Leighton, R. and N. Arden. A randomized blinded trial comparing one HA injection to corticosteroid for knee osteoarthritis pain. Oral presentation #640 AAOS,2010 New Orleans.
 
7) MA 12414 – Report of Prior Clinical Investigations DUROLANE